Zacks Company Profile for Apollo Endosurgery, Inc. (APEN : NSDQ) |
|
|
|
Company Description |
Apollo Endosurgery, Inc. is engaged in designing and manufacturing of medical devices for weight loss solutions and gastrointestinal disorders. The Company's product segment includes ORBERA (R), LAP-BAND (R) and OverStitch(TM). The ORBERA is an Intragastric Balloon System which is a weight loss aid for adults suffering from obesity. The LAP-BAND System is developed for weight reduction for patients with obesity. The OverStitch Endoscopic Suturing System enables endoscopic surgery. It operates primarily in Asia Pacific, European Office, Latin and South America and Costa Rica. Apollo Endosurgery, Inc., formerly known as Lpath, Inc., is headquatered in Austin, Texas.
Number of Employees: 107 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $4.11 |
Daily Weekly Monthly
 |
20 Day Moving Average: 149,452 shares |
Shares Outstanding: 40.25 (millions) |
Market Capitalization: $165.43 (millions) |
Beta: 2.26 |
52 Week High: $10.39 |
52 Week Low: $3.70 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-28.40% |
-21.86% |
12 Week |
-23.89% |
-19.87% |
Year To Date |
-51.25% |
-43.17% |
|
|
|
|
|
Address & Contact Information |
Street Address |
Phone / Fax |
Email Address |
Web URL |
1120 SOUTH CAPITAL OF TX HWY BUILDING 1 SUITE 300 - AUSTIN,TX 78746 USA |
ph: 512-279-5100 fax: 858-678-0900 |
ir@apolloendo.com |
http://www.apolloendo.com |
|
|
|
General Corporate Information |
Officers
Charles McKhann - Chief Executive Officer and Director
John Barr - Chairman
Jeffrey Black - Chief Financial Officer; Treasurer and Secretary
Chrissy Citzler-Carr - Controller
Julie Shimer - Director
|
|
Peer Information
Apollo Endosurgery, Inc. (ABMD)
Apollo Endosurgery, Inc. (DMDS)
Apollo Endosurgery, Inc. (CPWY.)
Apollo Endosurgery, Inc. (EQUR)
Apollo Endosurgery, Inc. (ECIA)
Apollo Endosurgery, Inc. (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 03767D108
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/02/22
|
|
Share - Related Items
Shares Outstanding: 40.25
Most Recent Split Date: 12.00 (0.18:1)
Beta: 2.26
Market Capitalization: $165.43 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $-0.21 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $-0.83 |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: 4.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: 7.00% |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/02/22 |
|
|
|
|